Sieve Health

Sieve Health

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Sieve Health is a San Francisco-based, AI-driven digital health startup founded in 2020 to address critical inefficiencies in clinical trial recruitment and management. The company's proprietary platform uses advanced algorithms to automate patient-trial matching, site selection, and performance monitoring, aiming to significantly reduce recruitment timelines and operational costs. By focusing on digitization, diversification, decentralization, and democratization of clinical trials, Sieve seeks to accelerate the development of new therapies and improve access for a broader, more representative patient population. The company is a private, likely pre-revenue entity targeting the substantial and growing market for clinical trial optimization technologies.

Digital HealthAI / Machine LearningDiagnostics

Technology Platform

Proprietary AI-based platform for clinical trial feasibility, site selection, participant identification, and trial performance management. Focuses on automation to reduce administrative burden, enhance diversity, and enable decentralized trials.

Opportunities

The company operates in a large, inefficient market with strong tailwinds, including regulatory pushes for trial diversity, rapid adoption of decentralized trial models, and increased investment in AI for healthcare operations.
Successfully proving its platform's ROI in speeding recruitment and lowering costs could lead to rapid adoption by pharmaceutical sponsors and CROs.

Risk Factors

Key risks include technology validation risk, as the AI must outperform traditional methods; intense competition from established clinical tech vendors and other startups; and the significant challenge of integrating with legacy systems and changing entrenched workflows within a risk-averse industry.

Competitive Landscape

Sieve competes in a crowded market with large, established clinical trial technology suites (e.g., Veeva, Medidata), internal solutions from major CROs (IQVIA, PPD), and a growing number of AI/ML-focused startups targeting recruitment and trial optimization. Differentiation hinges on proving superior algorithm performance, a focus on diversity, and seamless support for decentralized models.